QuidelOrtho Corporation QuidelOrtho Corporation

QuidelOrtho Corporation

QDEL

Rankning i aktier #9350
QuidelOrtho Corporation specializes in the creation and production of... QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression. The Transfusion Medicine unit focuses on ensuring blood safety and compatibility by offering immunohematology and infectious disease screening tests for blood and plasma. For rapid results in various clinical environments, the Point-of-Care segment delivers quick diagnostic tests. Additionally, the Molecular Diagnostics arm develops advanced polymerase chain reaction thermocyclers, analyzers, and amplification systems. QuidelOrtho distributes its offerings both directly to end-users and through an extensive network of distributors. These products are utilized by professionals in settings such as medical offices, hospitals, clinical and reference laboratories, urgent care centers, universities, retail clinics, pharmacies, wellness screening centers, and blood/donor banks, as well as for individual, non-professional, and over-the-counter applications. Founded in 1979 and based in San Diego, California, the company maintains a global footprint, including operations across North America, Europe, the Middle East, Africa, and China.
Aktiekurs
$14.24
Senast synkroniserad: 2026-10-20
Marknadsvärde
$976.51M
Förändring (1 dag)
11.60%
Förändring (1 år)
-66.95%
Land
US
Handel QuidelOrtho Corporation (QDEL)

Kategori

Healthcare
Vinst för QuidelOrtho Corporation (QDEL)
Vinst i 2026 TTM: 0
Enligt de senaste finansiella rapporterna från QuidelOrtho Corporation är företagets nuvarande vinst 0. År 2026 hade företaget en vinst på 0, lika med vinsten år 2026 som var 0. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för QuidelOrtho Corporation från 2026 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
Inte tillräckligt med data för de angivna datumen.
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH